GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sundry Debtors | ₹1,858 Cr | ₹3,665 Cr | ₹3,101 Cr | ₹2,572 Cr | ₹2,409 Cr |
What is the latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS ?
Year | Sundry Debtors |
---|---|
Mar2024 | ₹1,858 Cr |
Mar2023 | ₹3,665 Cr |
Mar2022 | ₹3,101 Cr |
Mar2021 | ₹2,572 Cr |
Mar2020 | ₹2,409 Cr |
How is Sundry Debtors of GLENMARK PHARMACEUTICALS Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2024 | ₹1,858 Cr | -49.30 | |
Mar2023 | ₹3,665 Cr | 18.19 | |
Mar2022 | ₹3,101 Cr | 20.57 | |
Mar2021 | ₹2,572 Cr | 6.77 | |
Mar2020 | ₹2,409 Cr | - |
Compare Sundry Debtors of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹42,678.5 Cr | 3% | -1.6% | 70.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹440,050.0 Cr | 2.7% | 0.9% | 34.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,208.0 Cr | -1.1% | 1.1% | 57.7% | Stock Analytics | |
CIPLA | ₹117,197.0 Cr | 0.6% | -1.7% | 8.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,586.0 Cr | -1.6% | -4.6% | 14.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,496.4 Cr | -0.5% | 2.5% | 36% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | 3% |
-1.6% |
70.8% |
SENSEX | -0.7% |
-2.6% |
7.5% |
You may also like the below Video Courses